- $2.22bn
- $2.49bn
- $1.15bn
- 72
- 49
- 82
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 718 | 1,052 | 992 | 1,026 | 1,153 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 609 | 778 | 745 | 789 | 945 |
Operating Profit | 109 | 275 | 247 | 236 | 208 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 82.2 | 248 | 219 | 201 | 178 |
Provision for Income Taxes | |||||
Net Income After Taxes | 63.8 | 212 | 190 | 165 | 146 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 29.6 | 118 | 106 | 90.5 | 81.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 30.4 | 190 | 169 | 93.3 | 131 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.21 | 4.4 | 3.99 | 3.51 | 3.12 |
Dividends per Share | |||||
Special Dividends per Share |